Silverfort is a cybersecurity company that provides a Unified Identity Protection platform designed to secure authentication across all users, devices, and systems in both on-premise and multi-cloud environments. Their key products include Multi-Factor Authentication (MFA), Risk-Based Authentication, and Identity Threat Detection and Response, which collectively help organizations prevent identity-based attacks and comply with various regulations. Silverfort differentiates itself by offering agentless and proxyless solutions that extend protection to previously unprotected systems, such as legacy applications and service accounts, without requiring modifications to existing infrastructure. With a strong market position and recognition as a leader in identity security, Silverfort has gained traction among enterprises looking to enhance their cybersecurity posture.
Quantum Machines is a global leader in control systems for quantum computing, providing innovative hardware and software solutions that scale from individual qubits to expansive arrays. Their products, including the OPX and QUA, enable researchers to conduct advanced quantum experiments with unmatched performance and ease of use. The company differentiates itself through its focus on real-time processing, intuitive programming, and bespoke support for physicists, positioning itself as a trusted partner in the rapidly growing quantum computing market. With a strong presence in leading labs and research institutions worldwide, Quantum Machines is at the forefront of advancing quantum technology.
Aqua Security is a pioneer in securing containerized cloud native applications from development to production. The Aqua Platform, a Cloud Native Application Protection Platform (CNAPP), integrates security from code to cloud, combining agent and agentless technology into a single solution. Founded in 2015, Aqua is headquartered in Boston, MA and Ramat Gan, IL, protecting over 500 of the world’s largest enterprises. Their full lifecycle solution prevents attacks by enforcing pre-deployment hygiene and mitigates attacks in real time, reducing mean time to repair and overall business risk. Aqua's solutions are designed to enable organizations to move to cloud native safely, addressing the security challenges posed by modern technology stacks.
ScyllaDB is a high-performance NoSQL database designed for data-intensive applications, offering predictable performance at scale. With its close-to-the-metal architecture, ScyllaDB can handle millions of operations per second with low latency, making it suitable for real-time applications. The company provides various offerings, including ScyllaDB Cloud, a fully-managed service on AWS and GCP, and ScyllaDB Enterprise, which includes premium features and dedicated support. ScyllaDB differentiates itself through its shard-per-core design and unified cache, allowing for efficient resource utilization and high availability. The company has gained traction with notable clients like Discord, Disney+, and Expedia, positioning itself as a leader in the NoSQL database market.
Aidoc is a provider of artificial intelligence healthcare solutions that empower physicians to expedite patient treatment and enhance efficiencies. Aidoc's AI-driven solutions analyze medical images directly after the patient is scanned, suggesting prioritization of time-sensitive pathologies, as well as notifying and activating multidisciplinary teams to reduce turnaround time, shorten length of stay and improve overall patient outcomes. Aidoc was founded in 2016 and is based in Tel Aviv, Israel.
Port is a developer platform designed to enhance developer experience and productivity by providing an internal developer portal that serves as a single source of truth for all engineering operations. It offers features such as developer self-service, automations, a software catalog, scorecards, and role-based access control, enabling teams to streamline their workflows and improve compliance. With a strong background in platform engineering, Port has already been adopted by over 1500 developers, positioning itself as a leader in the internal developer portal market.
Buildots is revolutionizing the construction industry with its AI-powered platform that automates progress tracking and work planning. By providing a comprehensive dashboard that consolidates site data, Buildots enables construction teams to predict delays, maintain momentum, and enhance collaboration. The platform's advanced analytics and predictive capabilities help reduce delays by up to 50%, making it a leading solution in construction management. With over 200 employees and operations in 12+ countries, Buildots has established itself as a key player in the market, serving clients like Intel and Mace Group, and raising $121 million in funding to fuel its growth.
Unframe offers a platform for building custom AI solutions at scale. It provides rapid AI use case implementation, secure data handling, and seamless integration with existing systems. The platform uses a Blueprint Approach for more efficient results without sharing sensitive data. It's designed to meet enterprise needs, ensuring speed,accuracy, and full control over solutions without the risk of third-party dependencies.
Qodo is a quality-first generative AI coding platform that helps developers write, test, and review code within IDE and Git. It offers automated code reviews, contextual suggestions, and comprehensive test generation, ensuring robust, reliable software. Seamless integration maintains high standards of code quality and integrity throughout development.
Firebolt is the cloud data warehouse for builders of next-gen analytics experiences. Combining the benefits and ease-of-use of a modern architecture with sub-second performance at terabyte scale, Firebolt helps data engineering and dev teams deliver data applications that end-users love.
Immunai is a biotech company focused on decoding the immune system through an AI model that facilitates the development of next-generation immunomodulatory therapeutics. By leveraging multi-omic single-cell analysis, machine learning, and functional genomics, Immunai addresses core challenges in drug development, including clinical trial optimization, preclinical asset evaluation, and target discovery. The company differentiates itself with a multidisciplinary team of experts and a unique engineering-first approach, aiming to bring breakthrough medicines to patients. With strategic partnerships with big pharma and research institutions, Immunai is positioned to advance novel therapeutics and accelerate R&D in the immunology space.